Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Brand names: Imbruvica
12.1 Mechanism of Action Ibrutinib is a small-molecule inhibitor of Bruton’s tyrosine kinase (BTK). Ibrutinib forms a covalent bond with a cysteine residue in the BTK active site, leading to inhibition of BTK enzymatic activity. BTK is a signaling molecule of the B-cell antigen receptor (BCR) and cytokine receptor pathways. BTK’s role in signaling through the B-cell surface receptors results in activation of pathways necessary for B-cell trafficking, chemotaxis, and adhesion. Nonclinical studies show that ibrutinib inhibits malignant B-cell proliferation and survival in vivo as well as cell migration and substrate adhesion in vitro .
Contraindications
7 documented side effects by frequency
9 Reddit threads analysed for IBRUTINIB
Overall Sentiment
Slightly positive
Comparison Threads
0
Avg Post Score
48 upvotes
Most discussed side effects in community
Hey everyone, get ready for some deep due diligence, this time not for REGAL, but for SLS-009, buyout, and what the future will look like with buyout from a strategic acquirer. Before I start, I would suggest for those haven’t yet, read Part 1 and Part 2 that goes over the deep due diligence and mac
Hey everyone, get ready for some deep due diligence, this time not for REGAL, but for SLS-009, buyout, and what the future will look like with buyout from a strategic acquirer. Before I start, I would suggest for those haven’t yet, read Part 1 and Part 2 that goes over the deep due diligence and mac
Hi everyone. I’m looking for insight from others with CLL experience. My dad has CLL with 96% involvement in his bone marrow per recent biopsy. His platelets are low, and over the past two weeks his anemia has worsened very very quickly. Recent timeline: Hospitalized with hemoglobin \~7.5 and fever
To Those Who Wish to learn, I feel like I may be giving away a secret.... but... here it goes... Earlier today I had a [twitter conversation](https://twitter.com/sentivcapital/status/1663230898702106634) about AI in regards to potential for future impact on stocks. I received a lot of DMs and to be
I’ve been pretty successful in a media career but now, at 43, 3 years post my diagnosis with my cancer under control (no cure... a rare lymphoma/on ibrutinib forever) two kids 7 and 4 at home and the sole breadwinner for the family, I’m so disenchanted. I finally feel great health wise... back to m
I was researching to find out * Examples of cancer drugs in the past that came to market later where treatments already existed, but ended up being commercially successful - * What were the characteristics of these late entrants that led to their success and does Cosibelimab have some of these char
**Is progression a meaningful outcome measure for a patient with indolent lymphoma** **If I don't feel anything (i.e. asymptomatic) and can live for decades with my lymphoma should I even worry about the fact that I have some enlarged lymph nodes or abnormalities of my lab work ???** I had a dis
Apparently a patient had been administering the medication this way... It's on the ISMP do not crush list. I called the manufacturer (Pharmacyclics) and they had no data on administering through any enteral feeding tubes, so they recommended not to give the medication in this manner. I can't find an
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
15 available comparisons
Dosage Forms
Tablet
Route
Oral